JAPAN DEAL
August 1st, 2004
BY KEITH NUTHALL
THE EUROPEAN Commission has approved a merger between Japan-based pharmaceutical companies Yamanouchi Pharmaceutical Co., Ltd and Fujisawa Pharmaceutical Co., Ltd. Brussels investigated the deal as they have significant Europe sales, concluding that their businesses were "largely complementary" and that the merged company (called Yamanouchi) will "face competition from larger players in Europe".
THE EUROPEAN Commission has approved a merger between Japan-based pharmaceutical companies Yamanouchi Pharmaceutical Co., Ltd and Fujisawa Pharmaceutical Co., Ltd. Brussels investigated the deal as they have significant Europe sales, concluding that their businesses were "largely complementary" and that the merged company (called Yamanouchi) will "face competition from larger players in Europe".
Full access to this article can be arranged with permission from the client that first ordered it. Please contact us to request access. Entries are uploaded to our archive at least one year after being published by a client – free access is restricted to International News Services journalists for background research only. The article date indicates when copy was filed to a client, not when posted to this archive. Upon client requests, International News Services will remove such articles from the archive or not upload them in the first place. They are included to demonstrate the breadth of topics undertaken by the agency and also to help promote clients’ coverage.